Login to Your Account

Certainty in an Uncertain Market?

Antigenics Success in Russia, Also a 'Personalized' Win

By Tiffany Turner

Monday, April 21, 2008
Personalized medicine became more than a buzzword two weeks ago. When the Russian Ministry of Public Health approved Oncophage, Antigenics Inc.'s cancer vaccine, it marked the first such approval for a personalized vaccine from a major country, and it shines new light on that system of disease treatment and management. (BioWorld Financial Watch)

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription